therapy
Combined inhibition of neutral endopeptidase 24.11 (NEP) and angiotensin       converting enzyme (ACE) is a candidate therapy for hypertension and cardiac       failure.
Combined inhibition of neutral endopeptidase 24.11 (NEP) and angiotensin       converting enzyme (ACE) is a candidate  @SUBJECT$   @PREDICAT$  hypertension and  @OBJECT$ .